Fox Chase Cancer Center News

CHICAGO (May 19, 2015) — African-American patients have a disproportionately high rate of cancer, and yet are less likely than Caucasian patients to participate in oncologic clinical trials that can significantly improve quality of life. Researchers from Fox Chase Cancer Center and Temple University recently explored the differences between African Americans who did and did not participate in a clinical trial and found significant discrepancies in perceptions and beliefs between the two groups. Lead study author Daniel M. Geynisman, MD, attending physician and assistant professor of medical oncology at Fox Chase, will present these findings during a poster session on Monday, June 1 at the 2015 American Society of Clinical Oncology Annual Meeting in Chicago.

CHICAGO (May 18, 2015) — Although various drugs have improved outcomes for metastatic colon cancer patients, researchers continually strive to find new agents to improve treatment. Antibody-drug conjugates are a promising option, due to the fact that they can deliver chemotherapy directly into a targeted cell and destroy tumor cells while keeping healthy ones intact.

Immersion Science Health Careers Symposium 2015 Offers Professional Presentations and Interactive Experience

PHILADELPHIA (May 10, 2015)—Faculty and staff, volunteers, patients, survivors, and their families will come together as members of the Fox Chase Cancer Center/Temple Health team at Susan G. Komen Philadelphia’s 25th Annual Race for the Cure on Mother’s Day—Sunday, May 10, 2015.

Philadelphia, PA (April 27, 2015) – Sixty-one (61) Temple physicians have been named to Philadelphia magazine’s “Top Doctors” list for 2015.  Physicians on the list were nominated by their professional peers, and practice at Temple University Hospital, Fox Chase Cancer Center, Jeanes Hospital and in the community as part of Temple Physicians, Inc.

PHILADELPHIA (April 17, 2015)— A new surgical approach that removes the fallopian tubes while sparing the ovaries may provide premenopausal women at high risk for ovarian cancer, particularly those with BRCA1/2 mutations, with a cancer risk–minimizing surgical option that also reduces some negative effects of ovary removal at a young age, according to a review published in the May issue of Cancer Prevention Research, a journal of the American Association for Cancer Research.

Researchers at Fox Chase Cancer Center found many similarities between ADPKD and cancer’s signaling pathways and inhibitors, highlighting potential avenues for the use of existing cancer therapeutics in the treatment of ADPKD.

Temple University Hospital/Fox Chase Cancer Center to Offer Free Screenings During Oral, Head and Neck Cancer Awareness Week®,

PHILADELPHIA (April 10, 2015)— Just because you can’t feel it, doesn’t mean it isn’t there.  Just ask the more than 100,000 Americans who were diagnosed with cancers of the head and neck (including thyroid) last year.